Progression of mild Alzheimer’s disease: knowledge and prediction models required for future treatment strategies

INTRODUCTION: Knowledge of longitudinal progression in mild Alzheimer’s disease (AD) is required for the evaluation of disease-modifying therapies. Our aim was to observe the effects of long-term cholinesterase inhibitor (ChEI) therapy in mild AD patients in a routine clinical setting. METHODS: This...

Descripción completa

Detalles Bibliográficos
Autores principales: Wattmo, Carina, Wallin, Åsa K, Minthon, Lennart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978889/
https://www.ncbi.nlm.nih.gov/pubmed/24099236
http://dx.doi.org/10.1186/alzrt210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978889/
https://www.ncbi.nlm.nih.gov/pubmed/24099236
http://dx.doi.org/10.1186/alzrt210

Ejemplares similares